Safeguard Scientifics Inc.

As President and Chief Executive Officer of Safeguard, Peter J. Boni draws on more than 25 years of experience as the CEO of technology companies in all stages of growth, and as an operating partner with a large global private equity firm. With both the deal savvy and operating expertise that a successful career affords, Peter is responsible for developing and executing Safeguard’s corporate strategy. His goal is to build on the company’s legacy of identifying businesses in the Technology and Life Sciences sectors with superior growth potential, and applying Safeguard’s capital and strategic, operational and management resources to enhance long-term value for shareholders, partner companies and employees. Peter is recognized as a leader in both building businesses and restoring troubled companies to growth and profitability. In addition to acting as CEO for several publicly-traded and privately-held companies, he has served as a chairman, a Fortune 500 corporate executive, a NYSE Fortune 1000 president, a management consultant, board member, investor and advisor to institutional investors in both early- and later-stage hardware, software and technology-enabled services firms. After his CEO experience, Peter served as an Operating Partner at Advent International, a leading global private equity firm managing $10 billion. Under Peter’s stewardship, several noteworthy firms were funded, grown and positioned for liquidity at premiums. Others were recognized among the Inc. 500 as fastest growing private companies. Several were brought to IPO. Some acquired and integrated with the acquired businesses, and/or were themselves acquired by industry leaders such as Computer Associates and Cisco Systems. As a result, Peter was recognized by Ernst & Young as an Entrepreneur of the Year finalist in New England. A decorated combat veteran, Peter served as an Army infantry officer in Special Operations in Vietnam. Through this life-altering experience, he developed a personal philosophy about the importance of surrounding himself with highly competent, well-trained and motivated individuals. It’s a philosophy he continues to lead his life by and one that he applies to his work every day at Safeguard. The opportunity to lead Safeguard appealed to Peter’s desire to apply both his strategic and deal-making experience to a forward-thinking company. His insights and lessons learned enable him to add value to Safeguard’s partner companies in areas where Safeguard can best apply its expertise, such as strategic planning, business development, sales, marketing, operations, mergers, acquisitions and finance. EXPERIENCE * Advent International – Operating Partner * Surebridge, Inc. – Chairman and CEO * Prime Response – CEO * Cayenne Software – CEO * Summa Four – CEO * On-Line Software International – President * Paramount Communications, Inc. (Software and Information Services Group) – President * Data General Corporation – Vice President & General Manager BOARD MEMBER Safeguard and Partner Companies * Clarient, Inc. (Nasdaq: CLRT) * Rubicor Medical, Inc. * Safeguard Scientifics, Inc. Independent Organizations * TechAmerica - Vice Chairman * National Foundation for Teaching Entrepreneurship (NFTE) – Advisory Board co-Chair EDUCATION * BA, University of Massachusetts at Amherst

As Senior Vice President and Chief Financial Officer, Steve leverages more than 25 years of strategic, financial and operational experience in raising capital and providing financial oversight, which greatly benefits Safeguard’s shareholders and partner companies. During the course of his career, Steve has demonstrated an ability to successfully grow and manage entrepreneurial enterprises. As Senior Vice President and Chief Financial Officer, Steve is responsible for all financial and administrative matters for Safeguard. He is also directly involved in providing oversight and support to Safeguard's partner companies, as well as participating in the development of Safeguard's long-term business strategy. Steve has the necessary public company skills that will ultimately drive value in Safeguard and its partner companies. Steve is responsible for analyzing and helping to identify the value-add that each partner company brings to Safeguard and its shareholders. Steve's experience complements Safeguard’s rich history and ensures a strong, disciplined financial infrastructure which drives excellence and accountability. Steve served as the interim Chief Financial Officer of Safeguard from December 2006 to June 2007. Prior to joining Safeguard, Steve held a number of financial and operating roles in both venture-backed and publicly traded companies. Today, in addition to his responsibilities at Safeguard, he is also the non-executive Chairman of the Penn Valley Group, a middle-market management advisory firm which launched in 2005. Prior to the creation of the Penn Valley Group, Steve served as the Chief Financial Officer of Fiberlink Communications Corp., a leading provider of remote access VPN solutions for large enterprises. Steve’s prior experience includes serving both as the Chief Financial Officer and then Chief Executive Officer of US Interactive, Inc. where he led the company’s initial and secondary public offerings. Steve also served as Chief Executive Officer of Concellera Software, Inc., orchestrating the sale of its proprietary technology to Hewlett Packard, and spent over a decade with Deloitte & Touche, where he was responsible for developing an emerging business practice for the firm in Philadelphia. The opportunity to rejoin Safeguard in June 2008 as its full time permanent Chief Financial Officer appealed to Steve’s desire to further apply his strategic, financial and operating skills to a broad array of companies. Steve has raised more than $200 million of growth capital through both venture sources and public offerings for a number of businesses. The application of these skills along with the financial oversight responsibilities of Safeguard serve to significantly leverage Steve’s substantial experiences for the benefit of Safeguard’s shareholders and partner companies. EXPERIENCE * Penn Valley Group – Founder and Managing Partner * Fiberlink Communications Corp – CFO * Concellera Software, Inc. – CEO * US Interactive, Inc. – CFO and CEO * Deloitte & Touche – Senior Manager BOARD MEMBER Safeguard and Partner Companies * Advantage Healthcare Solutions, Inc. * Clarient, Inc. (Nasdaq: CLRT) Independent Organizations * Arts & Business Council of Greater Philadelphia – Treasurer * Cadient, Inc. * Drexel University LeBow College of Business, Center for Corporate Governance Economics Pennsylvania – Regional Chairman * FMP Media, Inc. – Chairman * Internet Fitness, LLC * LaSalle University – Business Advisory Board * NutriSystem, Inc. (NASDAQ:NTRI) – Director and Chairman of Audit Committee EDUCATION * BS, LaSalle University

As Senior Vice President and General Counsel, Brian has executive responsibility for Safeguard’s legal affairs, mergers & acquisitions, support of Safeguard’s Board and public company activities, and direct participation in Safeguard’s business strategy. He is also responsible for managing compensation programs, performance programs and other human resources activities at Safeguard. Brian has more than 20 years of legal, operational, venture capital and public company experience in a high-tech setting, which further strengthens the depth of expertise and leadership within our organization. Safeguard is well positioned as a holding company to execute upon its game plan to deploy capital in new, high-potential situations, build value in our partner companies and realize that value in well-timed exits. Brian’s extensive knowledge of relationship management, M&A and other strategic transactions will enable Safeguard to continue to produce genuine results and be innovative as we execute upon our strategy. Brian comes to Safeguard from Traffic.com, a former Safeguard Partner Company and a leading provider of accurate, real-time traffic information in the United States, where he was Senior Vice President and General Counsel. Brian's legal, corporate finance, general management background and extensive public company experience proved invaluable to Traffic.com during the process of its acquisition by NAVTEQ Corporation (NYSE: NVT) earlier this year. Previously, Brian was Chief Operating Officer of Halo Technology Holdings, a public holding company for enterprise software businesses. Prior to that, he was Managing Director at Katalyst LLC, a venture capital and consulting firm; General Counsel of National Media Corporation, a public multimedia company with operations in 70 countries; and was a Partner at Klehr, Harrison, Harvey, Branzburg & Ellers LLP, a full-service Philadelphia-based law firm. Brian is a native of the greater Philadelphia region. He received a BS from Bucknell University and a JD from the University of Pennsylvania Law School. EXPERIENCE * Traffic.com – Senior Vice President and General Counsel * Halo Technology Holdings – Chief Operating Officer * Katalyst LLC – Managing Director * National Media Corporation – General Counsel * Klehr, Harrison, Harvey, Branzburg & Ellers LLP – Partner EDUCATION * BS, Bucknell University * JD, University of Pennsylvania Law School

As a member of Safeguard’s executive team, Kevin uses his market insight, business acumen and strategic vision to identify opportunities for Safeguard to partner with entrepreneurial companies in financial and fintech/payments, healthcare IT and Internet-based businesses. Kevin evaluates new opportunities and provides strategic and operational leadership to Safeguard and its rapidly growing partner companies. With over 10 years of experience in supporting entrepreneurs through venture capital, consulting, M&A transactions and strategic planning, Kevin has a deep understanding of the challenges and opportunities facing Safeguard partner companies. Kevin has provided capital to and served in senior management positions with companies representing all stages of growth. Prior to joining Safeguard in June 2004, Kevin was a director with Kennet Venture Partners, where he sourced and managed software and technology-enabled services investments. He also served as a principal at Broadview International, where he co-led the firm’s Silicon Valley team focused on mergers and acquisitions in the software applications market. Earlier in his career, he was a manager in Deloitte & Touche’s Management Consulting practice and a software developer at Salomon Brothers. Kevin received his MBA with a concentration in Entrepreneurial Management from The Wharton School of the University of Pennsylvania, and his BE in Electrical Engineering and Computer Science from Vanderbilt University. Kevin has established himself as a leader in the technology industry, having recently been recognized with the Philadelphia Business Journal’s ’40 under 40’ Award in 2008. Additionally, Kevin is a member of the Mid-Atlantic Capital (MAC) Alliance and the IT Investment Advisory Committee for the Ben Franklin Technology Partners of Southeastern Pennsylvania. He is also on the board of the Association for Corporate Growth (ACG) and serves as co-chair for ACG Philadelphia’s Program Committee. Additionally, he has served as a judge for the Eastern Technology Council’s Enterprise Awards. Kevin is a founding member of MindShare Philadelphia, a forum designed for aspiring technology and life sciences CEOs to collaborate and learn from their peers. He is also a member of the Board of Directors for Safeguard’s portfolio companies Advantedge Healthcare Solutions, Authentium and Bridgevine. EXPERIENCE * Kennet Venture Partners – Director * Broadview International – Principal, M&A * Deloitte & Touche – Manager, Management Consulting * Salomon Brothers – Senior Programmer / Analyst BOARD MEMBER Safeguard Partner Companies * Advantedge Healthcare Solutions, Inc. * Authentium, Inc. * Bridgevine, Inc. Independent Organizations * Association for Corporate Growth (ACG) – Program Committee Co-Chair * Ben Franklin Technology Partners – Investment Advisory Board EDUCATION * BEE, Vanderbilt University * BCS, Vanderbilt University * MBA, The Wharton School

Gary brings more than 17 years of experience in operations and investments, leveraging his medical expertise to enable businesses to enhance their products and grow their services, as well as to discover new partnering potential in developing entrepreneurial companies. Gary is responsible for identifying and partnering with entrepreneurial life sciences companies focused on molecular diagnostics, medical devices, regenerative medicine and specialty pharmaceuticals. He provides his operational expertise and knowledge to assist Safeguard’s existing partner companies to successfully develop, launch and optimize their products and services. Gary joined Safeguard from BioAdvance, a state initiative committed to funding early-stage life sciences companies, where he served as Managing Director and Chief Operating Officer. Previously, he was Chief Executive Officer at Pluvita Corporation, a company developing biological and bioinformatic solutions for drug and diagnostic development. Gary also previously served as Chief Operating Officer at Genovo, Inc., a gene therapy start-up company. He was also employed as head of research & development by Avigen, Inc., an early-stage gene therapy company located in San Francisco. Gary began his career with Gilead Sciences, Inc. – at the time, a pre-IPO biotechnology company – as virology group leader. A board-certified internist from BarnesHospital in St. Louis, MO, with a hematology sub-specialty, Gary has authored more than 40 research articles, book chapters and reviews, and is credited as inventor on twelve issued United States patents. Presently, Gary serves on various academic and biomedical committees and boards along with the editorial board of Biotechnology Healthcare. Presently, Gary is a lecturer in the Health Care Systems Department at the WhartonSchool at the University of Pennsylvania where he teaches entrepreneurship in life sciences. EXPERIENCE * BioAdvance – Managing Director and Chief Operating Officer * Pluvita Corporation – Chief Executive Officer * Genovo, Inc. – Chief Operating Officer * Avigen, Inc. – Vice President, R&D * Gilead Sciences, Inc. – Virology Group Leader * National Heart, Lung and Blood Institute – Research Fellow BOARD MEMBER Safeguard Partner Companies * Advanced BioHealing, Inc. * Alverix, Inc. – Chairman * Avid Radiopharmaceuticals, Inc. * Garnet Biotherapeutics, Inc. * Molecular Biometrics, Inc. * NuPathe, Inc. * Tengion, Inc. EDUCATION * BS, Stanford University * MD, Washington University and Stanford University

At Safeguard, John is responsible for developing, implementing and managing all aspects of the Company’s business development, corporate communications, strategic investor relations and marketing communications programs. John brings to Safeguard an extensive background in investor relations and a solid platform in communications. Over the course of his career, John has assisted national and multinational companies with corporate communications, initial public offerings (IPOs), mergers, acquisitions, divestitures, financial media relations, investor targeting, meeting programs and crisis management. Prior to joining Safeguard, John served as Vice President of Investor Relations at The Reynolds and Reynolds Company, a billion dollar software and services company. He played a key role in leading US operations as a managing partner for National Public Relations, Inc., a full service investor relations and corporate communications consulting firm. Prior to that, John was Director of Investor Relations at Thomson Financial/Georgeson & Company. He began his career at Robert Marston Corporate Communications after graduating from Susquehanna University. John is an active member of the National Investor Relations Institute. EXPERIENCE * The Reynolds and Reynolds Company – Vice President, Investor Relations and Corporate Communications * National Public Relations, Inc. * Thomson Financial / Georgeson & Company – Director, Investor Relations * Robert Marston Corporate Communications, Inc. EDUCATION * BA, Susquehanna University

As Executive Vice President and Managing Director of Life Sciences, Jim applies his broad industry knowledge to drive Safeguard’s partnership opportunities in Life Sciences. His significant experience as a marketing / sales and business development executive for leading pharmaceutical, medical device, diagnostics and software companies spans more than 20 years and covers assignments throughout the United States, Europe and Asia. Prior to joining Safeguard, Jim was Chief Executive Officer of TouchPoint Solutions, Inc., a provider of software that enables customers to develop and deploy applications, content and media on multi-user interactive devices. Prior to TouchPoint, Jim served as Group President of Dendrite International, a provider of sales, marketing, clinical and compliance solution services to global pharmaceutical and other life sciences companies. In his tenure as Group Director of Corporate Business Strategy and Planning at GlaxoSmithKline, he served on the Global Predictive Medicine Board of Directors, evaluating acquisition and alliance opportunities, reengineering projects and facilitating change management teams. His experience also includes executive international assignments setting up international businesses and identifying strategic growth opportunities for Merck KGaA and Baxter. As Chief Executive Officer at publicly traded Isuta Group, Jim redesigned the company’s value proposition and led a profitable expansion throughout Asia and enabled the company’s survival of the Asian economic crisis. These initiatives positioned the group to become a world leader in all major product groups. Jim and his team actively oversee Safeguard’s life sciences partner companies and continuously evaluate new growth opportunities in life sciences companies. Jim believes that by providing capital, as well as a range of strategic, operational and management resources, Safeguard is uniquely positioned to build value in growth-stage life sciences companies. Jim has completed more than 20 acquisitions, mergers and divestitures in his 20 plus years of experience, and seeks opportunities to partner with innovative entrepreneurs within diagnostics, medical devices and specialty pharmaceuticals. EXPERIENCE * TouchPoint Solutions, Inc. - CEO * Dendrite International - Group President * GlaxoSmithKline - Group Director, Corporate Business Strategy and Planning * Isuta Holdings - CEO * Baxter/Merck KGaA - Director, International Business BOARD MEMBER Safeguard Partner Companies * Cellumen, Inc. * Clarient, Inc. (Nasdaq: CLRT) * Molecular Biometrics, Inc. * Rubicor Medical, Inc. EDUCATION * BBA, Marshall University * MBA, University of New Haven

CEO and Chairman, Alliance Consulting Group, Inc., a business and information technology consulting company, since May 2004; Managing Director, Safeguard Scientifics, Inc., a technology operating company, from January 2002 to May 2004; Chairman and Chief Executive Officer, Ajunto, Inc., a privately held software company, from July 2001 to October 2001; President of Professional Services, Managing Director and Venture Partner, Internet Capital Group, a technology holding company, from December 1999 to June 2001; President of the Americas, President and Chief Operating Officer, Tech Data Corporation, a distributor of information technology products and services, from September 1996 to December 1999. Director Smartdisk Corporation.

Mr. DiPiano is a General Partner of NewSpring Ventures and the Managing Partner of NewSpring Capital.A Prior to joining NewSpring Capital, Mr. DiPiano was a serial entrepreneur and investor.A He led or co-led the investment into six companies in the business services, healthcare and information technology industries.A A During that time, he was affiliated with Safeguard Scientifics (NYSE:SFG) and their related Funds.A A Prior to 1996, he spent six years as a division CEO and director of Chemical Leaman Corporation.A A Mr. DiPiano started his career in 1980 with Baxter Healthcare Corporation (NYSE: BAX) where he held numerous positions culminating as Vice President responsible for Operations and Sales of the Industrial Scientific Products Division.A A He currently serves on the boards of Ecount; Femme Pharma; the Mid-Atlantic Capital Alliance, formerly known as the Greater Philadelphia Venture Group, which is a trade association representing over 80 Mid-Atlantic based private equity funds with approximately $12 billion under management, where he served as the 2005 program year Chairman; NutriSystem (NASDAQ: NTRI); Prescient Applied Intelligences (OTC BB: PPID); and the University City Science Center, where he sits on the investment committee. E-mail: MDiPiano@NewSpringCapital.com MDiPiano@NewSpringCapital.com

Mr. Millrood has over 25 years of experience directing technology organizations to develop, market and implement strategic solutions across a multitude of industries. For the past four years, Mr. Millrood served as Senior Vice President of Sales and Marketing at Epitome Systems, the leading provider of Enterprise Productivity Management (EPM) On-Demand. Prior to Epitome, Mr. Millrood was Group Vice President of Consulting for analyst firm The Gartner Group. In addition, he held sales leadership positions at Omicron Consulting, IBM and BusinessLand. Mr. Millrood received a Bachelor of Arts from Tulane University in 1980 and completed graduate work in International Relations at the University of Maryland in 1982.

Mr. Simon leads the North American Pharmaceutical Sales and Marketing Group for McKinsey & Company. He also is a director in the consulting firm’s Philadelphia office. He has considerable experience in addressing strategic and operational issues for a range of pharmaceutical, biotech and medical device manufacturers and diversified health care services companies.

George MacKenzie began his appointment on May 17, 2006 as non-executive Chairman of the Board of American Water, the largest investor-owned U.S. water and wastewater utility company. Mr. MacKenzie most recently served as interim president and CEO of American Water until the appointment of Donald L. Correll, which took effect April 17, 2006. He has been a valued member of the American Water Board of Directors since August 2003 and was a past Chair of the Audit Committee of the Board. In addition to his role with American Water, Mr. MacKenzie is a director on the Boards of Safeguard Scientifics, Inc., Tractor Supply Co., and C&D Technologies, Inc., where he served as Interim CEO early in 2005. He also serves on the Board of Trustees of the Medical Center of Delaware and is a member of the Investment Committee at the University of Delaware. George MacKenzie previously served as vice chairman of the Board and chief financial officer of Hercules Incorporated, a global manufacturer of chemical specialties whose 5,000 employees generated sales of approximately $2 billion in fiscal 2005. During his 22-year career with Hercules he served in a variety of senior management roles including president of the Chemical Specialty Division.

Array

Mark S. Speers is Managing Director and co-founder of Health Advances, LLC, a strategy consulting firm focused on the evaluation and commercialization of new medical technologies and services. Previously, Mr. Speers served as a Partner at Bain & Company where he consulted for major health and life sciences companies.

Dr. Snyder is the President and CEO of Decision Strategies International, a consulting firm focused on increasing the strategic aptitude of organizations through education, consulting and tools. He has over 20 years of experience in business leadership, strategic planning, decision support systems and technology management for both Fortune 500 companies and start-up ventures. Dr. Snyder has held executive positions with several Fortune 500 companies including GE, Martin Marietta and Lockheed Martin, and has advised numerous Fortune 500 clients and government organization on business and technology strategy. Dr. Snyder earned his Bachelor’s degree, Master’s degree and Ph.D. in Systems Engineering from the University of Pennsylvania and has an executive degree from USC in Telecommunications Management.

Stephen M. Goodman is a partner in the Business Transactions Practice and is co-chairman of the Firm's Global Technology Practice. His practice focuses on representing emerging growth companies in the technology and life sciences sectors. He has nurtured startup companies such as CDnow, VerticalNet, ICG Commerce, AirClic, and AANet.com. Using the firm's vast resources, he coordinates all aspects of the legal representation of such companies and concentrates on corporate finance and acquisitions. He is also a member of the Firm's Advisory Board. Before joining the firm, Mr. Goodman was a senior partner at Wolf Block, Schorr & Solis-Cohen where he served as chairman of the Corporate Law Department, chairman of the Hiring Committee, as a member of the Executive Committee and as chairman of the Venture Development Group. Stephen holds a B.S. from the University of Pennsylvania and an L.L.B. from the University of Pennsylvania Law School. Stephen's honors and affiliations include Editor-in-Chief of the University of Pennsylvania Law Review, former member of the Advisory Board to the Chairman of the U.S. Senate Judiciary Committee, former Adjunct Professor of Law, Georgetown University, the University of Pennsylvania and Rutgers University Law Schools, former Law Clerk to U.S. Supreme Court Justice William J. Brennan Jr. and Chief Judge David L. Bazelon of the U.S. Court of Appeals for the District of Columbia Circuit.